methantheline has been researched along with Substance-Related Disorders in 2 studies
Methantheline: A quaternary ammonium compound that acts as an antimuscarinic agent. It has been used in the treatment of PEPTIC ULCER, in gastrointestinal disorders associated with smooth muscle spasm, and in the management of urinary incontinence, and may also be used for the treatment of HYPERHIDROSIS.
Substance-Related Disorders: Disorders related to substance use or abuse.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakagawasai, O | 1 |
| Takahashi, K | 1 |
| Miura, Y | 1 |
| Nemoto, W | 1 |
| Obara, Y | 1 |
| Tan-No, K | 1 |
| YLVISAKER, RS | 1 |
2 other studies available for methantheline and Substance-Related Disorders
| Article | Year |
|---|---|
ERK5 inhibitor BIX02189 attenuates methamphetamine-induced hyperactivity by modulating microglial activation in the striatum.
Topics: Aniline Compounds; Animals; Calcium-Binding Proteins; Corpus Striatum; Hyperkinesis; Indoles; Methan | 2022 |
The use of methantheline bromide (banthine) in peptic ulcer and other gastrointestinal disorders; with special reference to its abuses.
Topics: Gastrointestinal Diseases; Methantheline; Minnesota; Parasympatholytics; Peptic Ulcer; Quaternary Am | 1952 |